Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @TFFPharma
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @TFFPharma
-
Prikvačeni tweet
This morning,
$TFFP rang the@Nasdaq opening bell. Thank you to our investors and shareholders for your ongoing support. Listen to President & CEO Glenn Mattes’ opening remarks and view the bell ringing here: http://bit.ly/2raFgNg#drugdelivery#pharmapic.twitter.com/J2wZv8TaOt
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
During this year's
#JPMWeek, CEO Glenn Mattes sat down with@proactive_uk to discuss the year ahead for#TFFP. Read more and watch the interview: http://bit.ly/37hlyzw#drugdelivery#pharmapic.twitter.com/CW10suQLUd
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
After
$TFFP rang the@Nasdaq opening bell, President & CEO Glenn Mattes and Dr. Bill Williams sat down with@MarketJane of LilaMax Media to discuss our innovative technology and recent IPO. Watch the interview: http://bit.ly/2uoXYT3#drugdelivery#pharmapic.twitter.com/YizMjB44WF
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr. Robert "Bill" Williams, scientific consultant and inventor of our patented Thin Film Freezing technology, has been named a
@AcadofInventors fellow for 2019. Congrats to@BillTXCeutics on such a well-deserved honor! Read more: https://bwnews.pr/2sX7fkH#drugdelivery#innovationpic.twitter.com/8PoA6NglvS
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Attending
#JPM2020?$TFFP, a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on our patented Thin Film Freezing platform, is open for#investor and#businessdevelopment meetings. https://bwnews.pr/2E8n3mY pic.twitter.com/S1utjI30OG
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
On Dec. 9th,
$TFFP reported our third quarter results. Q3 has been a time of key accomplishments for TFF Pharmaceuticals, including the successful completion of our $24M IPO on the@Nasdaq stock market. Read more: https://bwnews.pr/2E8CAmC#drugdelivery#pharmapic.twitter.com/qGNJ0v0gOJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today, we announced that our Phase 1 trial for voriconazole inhalation powder to treat invasive
#pulmonary aspergillosis (IPA) will be initiated later this week. Read more: https://bwnews.pr/2qKm2ye#clinicaltrial#drugdeliveryHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Exciting news:
@lavoiegroup is now our Agency of Record. As our#IR and corporate communications agency, LaVoieHealthScience will help develop investor and media awareness of$TFFP and the promise of our Thin Film Freezing (TFF) platform. Learn more:https://bwnews.pr/2KIUMqDHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
$TFFP works to#RewriteTomorrow with our Thin Film Freezing technology that addresses current drug delivery limitations. Join us Nov. 20 as we ring the@NASDAQ Opening Bell. Livestream the ceremony 9:15-9:31 a.m. ET on https://new.livestream.com/nasdaq/liveHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.